Dr. Roland K. Kafuuma, MD

Dr. Kafuuma practices at Southwest Memorial Hospital in Cortez, Colorado, part of Southwest Health System.

Dr. Kafuuma's NPI, 1962615732, was assigned on May 8, 2007. Dr. Kafuuma holds Colorado license 48370.

Dr. Kafuuma's primary practice is Southwest Memorial Hospital, at 1311 N Mildred Rd, Cortez, CO 81321 in Montezuma County. The practice phone is (970) 565-6666.

Dr. Kafuuma's primary practice is Southwest Memorial Hospital in Cortez, Colorado, part of Southwest Health System. The medical group on file is Southwest Health System. Dmand AI also links Dr. Kafuuma to 7 more medical groups, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kafuuma practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kafuuma's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kafuuma is licensed in Colorado.

CMS data shows 358 Medicare services from Dr. Kafuuma across 5 procedure codes in 2024, for 140 Medicare patients. Medicare paid $23,706 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Kafuuma in 2024. The largest group is 75 to 84, with 54 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kafuuma's median patient age at 78, with 84% women.

In 2024, Dr. Kafuuma wrote 231 Medicare Part D claims for 108 patients. 88% of them were for generic drugs. CMS names the drug for 79 of them, across 4 drugs with 11 or more claims each, at $315 in total drug cost. In 2017, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kafuuma for performance year 2024, reported as part of a group. Dr. Kafuuma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Kafuuma from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Revance Therapeutics, Inc. paid the most, $336.